Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Medero AS
AS
Active
Org 912580539
Landåsvegen 977, 2861
Landåsbygda
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2013 · 12 years old
6 employees
Monitor
Share
Norway
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Medero AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
32M
24M
16M
8M
0M
2021: 18M
18M
2021
2022: 21M (+17% vs 2021)
21M
+17%
2022
2023: 25M (+19% vs 2022)
25M
+19%
2023
2024: 24M (-4% vs 2023)
24M
-4%
2024
2025: 26M (+8% vs 2024)
26M
+8%
2025
EBITDA
NOK millions
2M
2M
1M
1M
0M
2021: 2M
2M
2021
2022: 2M (0% vs 2021)
2M
0%
2022
2023: 2M (0% vs 2022)
2M
0%
2023
2024: 2M (0% vs 2023)
2M
0%
2024
2025: 2M (0% vs 2024)
2M
0%
2025
Income statement
NOK thousands
Item
2025
2024
2023
2022
2021
Revenue
25 865
24 363
24 659
21 316
18 374
Staff expenses
−4 029
−3 868
−3 827
−2 876
−2 356
EBITDA
1 585
1 638
1 912
2 022
1 607
Depreciation & amort.
−537
−0
−0
−0
−0
EBIT
1 048
1 638
1 912
2 022
1 607
Net financials
−64
−24
−9
365
4
Profit before tax
984
1 613
1 903
2 387
1 611
Tax
216
354
419
525
354
Net profit
768
1 259
1 484
1 862
1 257
Balance sheet
NOK thousands
Item
2025
2024
2023
2022
2021
Total assets
9 955
9 509
7 615
7 379
6 499
Equity
5 987
5 219
3 960
2 476
1 815
Long-term debt
0
0
0
0
0
Short-term debt
3 967
4 290
3 655
4 902
4 684
Total debt
3 967
4 290
3 655
4 902
4 684
Financial ratios
5-year trend
EBITDA margin
6,1 %
This company
15,8 %
Market median
This company
Market median
61% below market
2021
2025
Equity ratio
60,1 %
This company
38,2 %
Market median
This company
Market median
57% above market
2021
2025
Return on equity
12,8 %
This company
18,4 %
Market median
This company
Market median
30% below market
2021
2025
Net profit margin
3,0 %
This company
8,1 %
Market median
This company
Market median
63% below market
2021
2025
Asset turnover
2,60×
This company
1,12×
Market median
This company
Market median
132% above market
2021
2025
Debt / equity
0,66×
This company
0,62×
Market median
This company
Market median
6% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
More on Medero AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
